ClearPoint Neuro (CLPT) Accumulated Expenses (2011 - 2026)

ClearPoint Neuro has disclosed Accumulated Expenses across 16 years of filings, most recently posting $3.0 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $3.0 million, up 53.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (up 53.14% YoY), and the FY2025 annual result was $4.4 million, down 10.75% from the prior year.
• Accumulated Expenses came in at $3.0 million for Q1 2026 at ClearPoint Neuro, down from $4.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $4.9 million in Q4 2024 to a low of $1.3 million in Q1 2022.
• The 5-year median for Accumulated Expenses is $2.8 million (2022), against an average of $2.7 million.
• Across the five-year window, Accumulated Expenses jumped 65.76% in 2024 and fell 10.75% in 2025, its largest moves.
• ClearPoint Neuro's Accumulated Expenses stood at $2.8 million in 2022, then increased by 4.36% to $2.9 million in 2023, then soared by 65.76% to $4.9 million in 2024, then retreated by 10.75% to $4.4 million in 2025, then sank by 31.72% to $3.0 million in 2026.
• The last three Accumulated Expenses figures came in at $3.0 million (Q1 2026), $4.4 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.